ProSciento Appoints Michelle Thompson, PhD, MBA, as Executive Vice President of Global Business Development Read More »
ProSciento Expands Executive Scientific Leadership, Appoints Dr. Julio Gutierrez as Vice President of Clinical Research and Clinical Science Read More »
View Recent Webinar
Pharmacokinetic and Pharmacodynamic Bioequivalence between regular human insulin [rDNA origin] in 0.9% sodium chloride ready-to-use infusion 1U/mL and in 100U/mL concentrate diluted to 1U/mL in Healthy Males. Read More »
TVB-2640 (FASN inhibitor) for the treatment of nonalcoholic steatohepatitis: FASCINATE-1, a randomized, placebo-controlled Ph2a trial. Read More »
Tolerability of eptinezumab in overweight, obese or type 1 diabetes patients. Read More »
